Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Higher Myocardial and Skeletal Muscle Microvascular Flow in Sickle Cell Disease Patients on Hydroxyurea

Caterina P. Minniti, MD, Vandana Sachdev, MD, Hannoush Hwaida, MD, Stanislav Sidenko, MD, Myron A Waclawiw, MD, Brenneman Cyndy, MD, Andrew E Arai, MD, Gregory J. Kato, MD, Jonathan R. Lindner, MD

Blood (2016) 128 (22): 1020.

https://doi.org/10.1182/blood.V128.22.1020.1020

Published: 2016

Journal Articles

Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity

Blood (2011) 118 (4): 855–864.

https://doi.org/10.1182/blood-2010-09-306167

Published: 2011

Includes: Supplemental data

Journal Articles

Impact of Hydroxyurea On Employment Among Patients with Sickle Cell Anemia.

Samir K. Ballas, MD, Robert L Bauserman, PhD, William F. McCarthy, Ph., D., Myron A Waclawiw, PhD, Bruce A Barton, PhD

Blood (2009) 114 (22): 2485.

https://doi.org/10.1182/blood.V114.22.2485.2485

Published: 2009

Journal Articles

Patterns of Analgesic Utilization in the Multicenter Study of Hydroxyurea (MSH).

Samir K. Ballas, MD, William F. McCarthy, Ph., D., Robert I Bauseman, PhD, Oswaldo L Castro, MD, Paul S. Swerdlow, MD, Wally Smith, Myron A Waclawiw, PhD, Bruce A Barton, PhD

Blood (2009) 114 (22): 2577.

https://doi.org/10.1182/blood.V114.22.2577.2577

Published: 2009

Journal Articles

Sickle Cell Genetic Markers: Geographic Distribution and Relation to Pain Outcomes in Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Samir K. Ballas, MD, William F. McCarthy, Ph., D., Robert L Bauserman, PhD, Oswaldo L Castro, MD, Myron A Waclawiw, PhD, Bruce A Barton, PhD

Blood (2009) 114 (22): 2582.

https://doi.org/10.1182/blood.V114.22.2582.2582

Published: 2009

Journal Articles

Developmental Outcomes of Offspring of Adults Treated with Hydroxyurea in the Multicenter Study of Hydroxyurea.

F. Daniel Armstrong, Ph.D., Martin H Steinberg, MD, Samir K. Ballas, MD, Kenneth I. Ataga, MD, Myron A Waclawiw, PhD, Abdullah Kutlar, MD, Paul S. Swerdlow, MD, William F. McCarthy, Ph., D., for the MSH Extension Investigators

Blood (2009) 114 (22): 1543.

https://doi.org/10.1182/blood.V114.22.1543.1543

Published: 2009

Journal Articles

Safety and Efficacy of Sildenafil Therapy for Doppler-Defined Pulmonary Hypertension in Patients with Sickle Cell Disease: Preliminary Results of the Walk-PHaSST Clinical Trial.

Roberto F Machado, MD, Robyn J Barst, MD, Nancy A Yovetich, PhD, Kathryn L Hassell, MD, Jonathan C. Goldsmith, MD, Rob Woolson, MS, JD, Victor R. Gordeuk, MD, Simon Gibbs, MD, Jane A Little, MD, Gregory J Kato, MD, Dean E Schraufnagel, MD, Lakshmanan Krishnamurti, MD, Reda E Girgis, MD, Claudia R. Morris, MD, Erika Berman-Rosenzweig, MD, David B Badesch, MD, Myron A Waclawiw, PhD, Mark Gladwin, MD

Blood (2009) 114 (22): 571.

https://doi.org/10.1182/blood.V114.22.571.571

Published: 2009

Journal Articles

Footprints of Response to Hydroxyurea Are in the Hemogram.

Samir K. Ballas, MD, William F. McCarthy, Ph., D., Nan Gua, Carlo Brugnara, MD, Gail M Kling, MS, Robert L Bauserman, PhD, Myron A Waclawiw, PhD

Blood (2009) 114 (22): 4619.

https://doi.org/10.1182/blood.V114.22.4619.4619

Published: 2009

Journal Articles

Pharmacokinetics of Hydroxyurea in Young Children with Sickle Cell Anemia: A Report from the BABY HUG Trial.

Zora R. Rogers, MD, Bruce Thompson, PhD, Russell E. Ware, MD, PhD, Winfred C. Wang, MD, Rathi V. Iyer, MD, Scott T. Miller, MD, Caterina Minniti, MD, Sohail Rana, MD, Julio C. Barredo, MD, Stuart Toledano, MD, Sherri A. Zimmerman, MD, James F. Casella, MD, Beatrice A. Files, MD, Myron A. Waclawiw, PhD, A. Russell Gerber, MD, Duane R. Bonds, MD

Blood (2005) 106 (11): 3184.

https://doi.org/10.1182/blood.V106.11.3184.3184

Published: 2005

NARROW

Higher Myocardial and Skeletal Muscle Microvascular Flow in Sickle Cell Disease Patients on Hydroxyurea

Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity

Impact of Hydroxyurea On Employment Among Patients with Sickle Cell Anemia.

Patterns of Analgesic Utilization in the Multicenter Study of Hydroxyurea (MSH).

Sickle Cell Genetic Markers: Geographic Distribution and Relation to Pain Outcomes in Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Developmental Outcomes of Offspring of Adults Treated with Hydroxyurea in the Multicenter Study of Hydroxyurea.

Safety and Efficacy of Sildenafil Therapy for Doppler-Defined Pulmonary Hypertension in Patients with Sickle Cell Disease: Preliminary Results of the Walk-PHaSST Clinical Trial.

Footprints of Response to Hydroxyurea Are in the Hemogram.

Pharmacokinetics of Hydroxyurea in Young Children with Sickle Cell Anemia: A Report from the BABY HUG Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only